Cochlear Bone Anchored Solutions
8
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
1 terminated/withdrawn out of 8 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
83%
5 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Single-stage Surgery Using the BI300 Implant
Role: collaborator
10-year Follow-up of a Wide Diameter Bone Anchored Hearing Implant
Role: collaborator
Evaluation of Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System
Role: lead
Clinical and Health Economic Evaluation With a New Baha® Abutment Combined With a Minimally Invasive Surgical Technique
Role: lead
Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System)
Role: lead
Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)
Role: lead
Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System
Role: lead
The Baha Microbiome Case Control Study
Role: collaborator
All 8 trials loaded